NPR News·3 min read·medium
A new flu vaccine geared to older people is coming soon
R
Rob Stein
✦AI Summary
The FDA has approved Moderna's mRNA-based flu vaccine, mFLUSIVA, for individuals aged 50 and older. The vaccine is expected to be available for the 2026-2027 respiratory season, marking a significant milestone for mRNA technology despite political opposition.
For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter .
healthsciencepolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in